Skip to main content
. 2020 Sep 24;10:15640. doi: 10.1038/s41598-020-72768-z

Table 2.

Treatment used for rheumatoid arthritis in our cohort.

2012, n (%) 2017, n (%) Duration of treatment, months
Methotrexate 27 (67.5) 23 (71.9) 57.5 (7.1)
Leflunomide 10 (25) 7 (21.9) 50.7 (16.7)
Prednisone 4 (10) 13 (40) 50.8 (16.4)
Biologic treatment 0 (0) 5 (15.6) 24 (6–48)

Results are expressed as mean (SD) or median (Q1–Q3) were applicable.